{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:49:34Z","timestamp":1791420574361,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Develop a multimodal fusion model combining MRI radiomics and deep learning (DL) to predict pathologic complete response (pCR) in breast cancer patients post-neoadjuvant chemotherapy (NACT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with locally advanced breast cancer from two centers (Center 1: 404 training, Center 2: 174 testing) were enrolled. Pretreatment MRI radiomic features and DL-derived features were extracted, selected via Minimum Redundancy Maximum Relevance and Least Absolute Shrinkage and Selection Operator, and integrated with clinical risk factors into a joint multimodal fusion model using XGBoost. The model was validated internally on an independent test cohort and externally on the Duke Breast Imaging Dataset (284 patients) to assess generalizability across diverse populations and imaging protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The fusion model achieved AUCs of 0.935 (training), 0.916 (testing), and 0.83 (external validation), surpassing standalone radiomics and DL models. External validation confirmed robustness to institutional variability, with strong calibration and clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The XGBoost-integrated radiomics-DL-clinical model accurately predicts pCR, validated across independent cohorts, and may optimize personalized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-026-02578-8","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:34:47Z","timestamp":1784014487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating MRI radiomics and deep learning for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study"],"prefix":"10.1186","volume":"26","author":[{"given":"Min","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohua","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"2578_CR1","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, et al. Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535. https:\/\/doi.org\/10.1016\/j.intimp.2020.106535.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2578_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.critrevonc.2015.02.011","volume":"95","author":"Q Wang-Lopez","year":"2015","unstructured":"Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier M-A, et al. Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer? Crit Rev Oncol\/Hematol. 2015;95(1):88\u2013104. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.02.011.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2578_CR3","doi-asserted-by":"publisher","unstructured":"Loibl S, Denkert C, von Minckwitz G. Neoadjuvant treatment of breast cancer \u2013 clinical and research perspective. Breast. 2015;24(Suppl, 2):S73\u20137. https:\/\/doi.org\/10.1016\/j.breast.2015.07.018.","DOI":"10.1016\/j.breast.2015.07.018"},{"issue":"9","key":"2578_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00268-019-05032-9","volume":"43","author":"N Yu","year":"2019","unstructured":"Yu N, Leung VWY, Meterissian S. MRI performance in detecting pCR after neoadjuvant chemotherapy by molecular subtype of breast cancer. World J Surg. 2019;43(9):2254\u201361. https:\/\/doi.org\/10.1007\/s00268-019-05032-9.","journal-title":"World J Surg"},{"issue":"1","key":"2578_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-017-0846-1","volume":"19","author":"NM Braman","year":"2017","unstructured":"Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57. https:\/\/doi.org\/10.1186\/s13058-017-0846-1.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"2578_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2214\/AJR.14.13047","volume":"204","author":"LJ Grimm","year":"2015","unstructured":"Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, et al. Interobserver variability between breast imagers using the fifth edition of the BI-RADS MRI lexicon. Am J Roentgenol. 2015;204(5):1120\u201324. https:\/\/doi.org\/10.2214\/AJR.14.13047.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"2578_CR7","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.3390\/tomography8060232","volume":"8","author":"N Khan","year":"2022","unstructured":"Khan N, Adam R, Huang P, Maldjian T, Duong TQ. Deep learning prediction of pathologic complete response in breast cancer using MRI and other clinical data: a Systematic Review. Tomography. 2022;8(6):2784\u201395. https:\/\/doi.org\/10.3390\/tomography8060232.","journal-title":"Tomography"},{"key":"2578_CR8","doi-asserted-by":"publisher","unstructured":"Li W, Partridge SC, Newitt DC, Steingrimsson J, Marques HS, Bolan PJ, et al. Breast multiparametric MRI for prediction of neoadjuvant chemotherapy response in breast cancer: the BMMR2 challenge. Radiol: Imag Cancer. 2024;6(1):e230033. https:\/\/doi.org\/10.1148\/rycan.230033.","DOI":"10.1148\/rycan.230033"},{"issue":"4","key":"2578_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, et al. Introduction to radiomics. J Nucl Med. 2020;61(4):488\u201395. https:\/\/doi.org\/10.2967\/jnumed.118.222893.","journal-title":"J Nucl Med"},{"issue":"9","key":"2578_CR10","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","volume":"5","author":"YJ Qi","year":"2024","unstructured":"Qi YJ, Su GH, You C, Zhang X, Xiao Y, Jiang Y-Z, et al. Radiomics in breast cancer: current advances and future directions. Cell Rep Med. 2024;5(9):101719. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101719.","journal-title":"Cell Rep Med"},{"key":"2578_CR11","doi-asserted-by":"publisher","unstructured":"Avanzo M, Wei L, Stancanello J, Valli\u00e8res M, Rao A, Morin O, et al. Machine and deep learning methods for radiomics. Med Phys. 2020;47(5):e185\u2013202. https:\/\/doi.org\/10.1002\/mp.13678.","DOI":"10.1002\/mp.13678"},{"key":"2578_CR12","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.tranon.2024.101985","volume":"46","author":"C Jiang","year":"2024","unstructured":"Jiang C, Zhang X, Qu T, Yang X, Xiu Y, Yu X, et al. The prediction of pCR and chemosensitivity for breast cancer patients using DLG3, RADL and pathomics signatures based on machine learning and deep learning. Transl Oncol. 2024;46:101985. https:\/\/doi.org\/10.1016\/j.tranon.2024.101985.","journal-title":"Transl Oncol"},{"issue":"2","key":"2578_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.9.2.14","volume":"9","author":"RY Choi","year":"2020","unstructured":"Choi RY, Coyner AS, Kalpathy-Cramer J, Chiang MF, Campbell JP. Introduction to machine learning, Neural Networks, and deep learning. Transl Vis Sci Technol. 2020;9(2):14. https:\/\/doi.org\/10.1167\/tvst.9.2.14.","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"2578_CR14","doi-asserted-by":"publisher","first-page":"10536","DOI":"10.1038\/s41598-020-67441-4","volume":"10","author":"Q Hu","year":"2020","unstructured":"Hu Q, Whitney HM, Giger ML. A deep learning methodology for improved breast cancer diagnosis using multiparametric MRI. Sci Rep. 2020;10(1):10536. https:\/\/doi.org\/10.1038\/s41598-020-67441-4.","journal-title":"Sci Rep"},{"issue":"7","key":"2578_CR15","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1007\/s00330-020-07640-9","volume":"31","author":"WC Ou","year":"2021","unstructured":"Ou WC, Polat D, Dogan BE. Deep learning in breast radiology: current progress and future directions. Eur Radiol. 2021;31(7):4872\u201385. https:\/\/doi.org\/10.1007\/s00330-020-07640-9.","journal-title":"Eur Radiol"},{"issue":"4","key":"2578_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41416-018-0185-8","volume":"119","author":"A Saha","year":"2018","unstructured":"Saha A, Harowicz MR, Grimm LJ, Kim CE, Ghate SV, Walsh R, et al. A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features. Br J Cancer. 2018;119(4):508\u201316. https:\/\/doi.org\/10.1038\/s41416-018-0185-8.","journal-title":"Br J Cancer"},{"issue":"4","key":"2578_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2559.2006.02419.x","volume":"50","author":"SE Pinder","year":"2007","unstructured":"Pinder SE, Provenzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50(4):409\u201317. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02419.x.","journal-title":"Histopathology"},{"issue":"11","key":"2578_CR18","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1158\/0008-5472.CAN-22-1183","volume":"82","author":"W Mu","year":"2022","unstructured":"Mu W, Schabath MB, Gillies RJ. Images are data: challenges and opportunities in the clinical translation of radiomics. Cancer Res. 2022;82(11):2066\u201368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1183.","journal-title":"Cancer Res"},{"key":"2578_CR19","doi-asserted-by":"publisher","first-page":"828904","DOI":"10.3389\/fonc.2022.828904","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Peng J, Liu J, Ma Y, Shu Z. Preoperative prediction of perineural invasion status of rectal cancer based on radiomics nomogram of Multiparametric Magnetic resonance imaging. Front Oncol. 2022;12:828904. https:\/\/doi.org\/10.3389\/fonc.2022.828904.","journal-title":"Front Oncol"},{"issue":"6","key":"2578_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.neuron.2020.09.005","volume":"107","author":"GR Yang","year":"2020","unstructured":"Yang GR, Wang XJ. Artificial Neural Networks for neuroscientists: a primer. Neuron. 2020, Sep, 23;107(6):1048\u201370. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.005 in:Neuron. 2021, 109(4):739.","journal-title":"Neuron"},{"issue":"5","key":"2578_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1615\/CritRevBiomedEng.2022044813","volume":"50","author":"N Suroor","year":"2022","unstructured":"Suroor N, Jaiswal A, Sachdeva N. Stack ensemble oriented parkinson disease prediction using machine learning approaches utilizing GridSearchCV-Based hyper parameter tuning. Crit Rev Biomed Eng. 2022;50(5):39\u201358. https:\/\/doi.org\/10.1615\/CritRevBiomedEng.2022044813.","journal-title":"Crit Rev Biomed Eng"},{"key":"2578_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","volume":"72","author":"A Conti","year":"2021","unstructured":"Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2021;72:238\u201350. https:\/\/doi.org\/10.1016\/j.semcancer.2020.04.002.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2578_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2022","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132\u201346. https:\/\/doi.org\/10.1038\/s41571-021-00560-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2578_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jinf.2023.07.006","volume":"87","author":"AA Theodosiou","year":"2023","unstructured":"Theodosiou AA, Read RC. Artificial intelligence, machine learning and deep learning: potential resources for the infection clinician. J Infect. 2023;87(4):287\u201394. https:\/\/doi.org\/10.1016\/j.jinf.2023.07.006.","journal-title":"J Infect"},{"issue":"10","key":"2578_CR25","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1007\/s12094-024-03459-8","volume":"26","author":"E Zhu","year":"2024","unstructured":"Zhu E, Zhang L, Liu Y, Ji T, Dai J, Tang R, et al. Determining individual suitability for neoadjuvant systemic therapy in breast cancer patients through deep learning. Clin Transl Oncol. 2024;26(10):2584\u201393. https:\/\/doi.org\/10.1007\/s12094-024-03459-8.","journal-title":"Clin Transl Oncol"},{"issue":"21","key":"2578_CR26","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.3390\/cancers13215477","volume":"13","author":"AJA Freitas","year":"2021","unstructured":"Freitas AJA, Causin RL, Varuzza MB, Hidalgo Filho CMT, Silva VDD, Souza CDP, et al. Molecular biomarkers predict pathological complete response of neoadjuvant chemotherapy in breast cancer patients: review. Cancers (Basel). 2021;13(21):5477. https:\/\/doi.org\/10.3390\/cancers13215477.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2578_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","volume":"170","author":"W Haque","year":"2018","unstructured":"Haque W, Verma V, Hatch S, Suzanne Klimberg V, Brian Butler E, Teh BS. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Res Treat. 2018;170(3):559\u201367. https:\/\/doi.org\/10.1007\/s10549-018-4801-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2578_CR28","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.3390\/ijms24032969","volume":"24","author":"van den Ende Ns","year":"2023","unstructured":"van den Ende Ns, Nguyen AH, Jager A, van den Ende NS, Kok M, Debets R, et al. Triple-negative breast cancer and predictive markers of response to neoadjuvant chemotherapy: a Systematic Review. IJMS. 2023;24(3):2969. https:\/\/doi.org\/10.3390\/ijms24032969.","journal-title":"IJMS"},{"issue":"3","key":"2578_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.20892\/j.issn.2095-3941.2022.0513","volume":"20","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang M, Yu K, Xu S, Qiu P, Lyu Z, et al. A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity. Cancer Biol Med. 2023;20(3):218\u201328. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0513.","journal-title":"Cancer Biol Med"},{"key":"2578_CR30","doi-asserted-by":"publisher","first-page":"1466825","DOI":"10.3389\/fgene.2024.1466825","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Xue X, Wen P, Song Q, Yao J, Ge S. Multi-fusion strategy network-guided cancer subtypes discovering based on multi-omics data. Front Genet. 2024;15:1466825. https:\/\/doi.org\/10.3389\/fgene.2024.1466825.","journal-title":"Front Genet"},{"issue":"11","key":"2578_CR31","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/jum.16535","volume":"43","author":"PS Oztekin","year":"2024","unstructured":"Oztekin PS, Katar O, Omma T, Erel S, Tokur O, Avci D, et al. Comparison of explainable artificial intelligence model and radiologist Review performances to detect breast cancer in 752 patients. J Ultrasound Med. 2024;43(11):2051\u201368. https:\/\/doi.org\/10.1002\/jum.16535.","journal-title":"J Ultrasound Med"},{"issue":"5","key":"2578_CR32","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00259-023-06513-9","volume":"51","author":"K Jannusch","year":"2024","unstructured":"Jannusch K, Dietzel F, Bruckmann NM, Morawitz J, Boschheidgen M, Minko P, et al. Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET\/MRI. Eur J Nucl Med Mol Imag. 2024;51(5):1451\u201361. https:\/\/doi.org\/10.1007\/s00259-023-06513-9.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"2578_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fonc.2020.00093","volume":"10","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Huang J, Liang J, Ma M, Ye K, Shi C, et al. The diagnostic performance of DCE-MRI in evaluating the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. Front Oncol. 2020;10:93. https:\/\/doi.org\/10.3389\/fonc.2020.00093.","journal-title":"Front Oncol"},{"key":"2578_CR34","doi-asserted-by":"publisher","first-page":"1366613","DOI":"10.3389\/fonc.2024.1366613","volume":"14","author":"Q Hu","year":"2024","unstructured":"Hu Q, Hu Y, Ai H, Xia L, Liu R, Ai T. Pre-operative MRI in evaluating pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer: a study focused on influencing factors of baseline clinical-pathological and imaging features. Front Oncol. 2024;14:1366613. https:\/\/doi.org\/10.3389\/fonc.2024.1366613.","journal-title":"Front Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02578-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02578-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02578-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:55:33Z","timestamp":1791417333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02578-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02578-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study complied with the Declaration of Helsinki. This study was a retrospective study and was approved by the ethics committee of Zhejiang Provincial People\u2019s Hospital, Zhejiang, China. The requirement for informed consent was waived by the Medical Ethics Committee. Authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"505"}}